Search

everythinglearnresearchcommunity

for

Search:↓

Type I interferons play a key role in the development of various skin diseases.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Retinoic acid may help heal skin without scars by reducing fibrosis and supporting skin regeneration.

Skin conditions can cause significant psychological distress, so addressing mental health is crucial for improving quality of life.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Oxidative stress and mitophagy play key roles in hair loss, suggesting potential treatment targets.

Dietary changes and supplements mostly did not improve alopecia areata.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

People with alopecia areata are more likely to have major depression, possibly linked to a specific genetic region.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

A new hair loss treatment combining minoxidil and cedrol improves hair growth and reduces side effects.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.